HRT Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.8M | Sell |
24,886
-132,775
| -84% | -$20.4M | 0.01% | 1162 |
|
|
2025
Q4 | $21.7M | Buy |
157,661
+18,802
| +14% | +$2.46M | 0.09% | 207 |
|
|
2025
Q3 | $17.8M | Buy |
138,859
+100,879
| +266% | +$12.3M | 0.08% | 219 |
|
|
2025
Q2 | $4.59M | Sell |
37,980
-8,718
| -19% | -$983K | 0.02% | 571 |
|
|
2025
Q1 | $5.21M | Sell |
46,698
-10,030
| -18% | -$1.07M | 0.04% | 423 |
|
|
2024
Q4 | $5.52M | Buy |
56,728
+36,882
| +186% | +$3.93M | 0.03% | 375 |
|
|
2024
Q3 | $2.28M | Buy |
+19,846
| New | +$2.25M | 0.01% | 832 |
|
|
2023
Q4 | – | Sell |
-4,179
| Closed | -$425K | – | 2877 |
|
|
2023
Q3 | $425K | Buy |
+4,179
| New | +$424K | ﹤0.01% | 1486 |
|
|
2023
Q1 | – | Sell |
-3,762
| Closed | -$341K | – | 3002 |
|
|
2022
Q4 | $341K | Buy |
+3,762
| New | +$317K | 0.01% | 1657 |
|
|
2022
Q2 | – | Sell |
-16,038
| Closed | -$1.41M | – | 3519 |
|
|
2022
Q1 | $1.41M | Sell |
16,038
-5,675
| -26% | -$491K | 0.01% | 819 |
|
|
2021
Q4 | $1.9M | Sell |
21,713
-6,187
| -22% | -$514K | 0.01% | 692 |
|
|
2021
Q3 | $2.28M | Buy |
+27,900
| New | +$2.51M | 0.01% | 648 |
|
|
2021
Q2 | – | Sell |
-23,848
| Closed | -$2.04M | – | 3345 |
|
|
2021
Q1 | $2.04M | Buy |
23,848
+13,625
| +133% | +$1.22M | 0.02% | 604 |
|
|
2020
Q4 | $965K | Buy |
+10,223
| New | +$893K | 0.02% | 696 |
|
|
2018
Q4 | – | Sell |
-2,950
| Closed | -$227K | – | 706 |
|
|
2018
Q3 | $227K | Buy |
+2,950
| New | +$218K | 0.04% | 307 |
|
|
2016
Q3 | – | Sell |
-3,233
| Closed | -$239K | – | 161 |
|
|
2016
Q2 | $239K | Buy |
+3,233
| New | +$223K | 0.15% | 81 |
|
Other funds holding NVS
